Advancing Breast Cancer Research: Uniting for Progress on World Breast Cancer Research Day 2023
Every year, on August 18th, the world comes together to observe World Breast Cancer Research Day—a day dedicated to raising awareness about breast cancer and highlighting the ongoing efforts to combat this pervasive disease. This global initiative serves as a platform for researchers, medical professionals, advocates, and organizations to unite in their mission to advance breast cancer research and improve the lives of those affected by it. In the spirit of collaboration and progress, KACTUS is playing a crucial role by offering a wide range of drug targets tailored specifically for breast cancer research. These drug targets serve as critical building blocks for the development of new therapies and interventions.
KACTUS Drug Targets for Breast Cancer Research
B7-H3 | HER2 | PD1 | VEGF |
CTLA4 | LAG-3 | PD-L1 | VEGFR-1 |
EGFR | OX40 | K-Ras | VEGFR-2 |
ERBB3 | p53 | TRAIL | VEGFR-3 |
World Breast Cancer Research Day stands as a poignant reminder of the global community's determination to combat breast cancer and improve the lives of those affected by this disease. Let us celebrate the progress achieved so far and recommit ourselves to advancing breast cancer research. Together, we can turn the tide in the fight against breast cancer and pave the way for a brighter, healthier future.
The KACTUS Team